AKT1 and prostate carcinoma: We speculated that although S6K activation suppresses AKT, as often seen in many other types of cells [22], in prostate cancer cells with DEPTOR depletion, AKT activation by overactivated mTORC2 could neutralize or counteract S6K effect.